APN 2021 - November 25-26

Dear Colleagues, It is my great pleasure to announce the 2021 APN meeting to be held virtually on November 25-26. Similar to previous years, the APN meeting this year invited speakers from various countries (10 APN countries plus USA and New Zealand) on various topics, which will make the 2021 APN meeting another unique pan-Asian forum in the region. Also like last year, the meeting includes a student session for podium presentations, which will encourage the participation of future pharmacometricians. Registration is free and its procedure and the program are found at https://apn-taiwan2021.conf.tw/. Satellite workshops are scheduled on November 23-24, the detail of which will be provided in the next announcement For more information, contact the local host Dr. Yunn-Fang Ho of National Taiwan University of Taiwan at [email protected]<mailto:[email protected]> The APN was created to enhance regional development and networking opportunities in pharmacometrics and to provide training opportunities to future pharmacometricians across Asia. Currently the APN has 15 member countries, and the detail is found at http://www.go-apn.org/. Best regards, APN Chair Kyungsoo Park --------------------------------------- Kyungsoo Park, PhD, MD Professor of Pharmacology Yonsei University College of Medicine 50-1 Yonsei-Ro, Seoul 03722, Korea Tel +82-2-2228-1735 / Fax +82-2-313-1894 상기 메일은 지정된 수신인 만을 위한 것이며 부정경쟁 방지 및 영업비밀보호에 관한 법률을 포함하여 관련 법령에 따라 보호의 대상이 되는 영업비밀, 산업기술 등을 포함하고 있을 수 있습니다. 본 문서에 포함된 정보의 전부 또는 일부를 무단으로 제3자에게 공개, 배포, 복사 또는 사용하는 것은 엄격히 금지됩니다. 본 메일이 잘못 전송된 경우, 발신인에게 알려주시고 즉시 삭제하여 주시기 바랍니다. The above message is intended solely for the named addressee and may contain trade secret, industrial technology or privileged and confidential information otherwise protected under applicable law including the Unfair Competition Prevention and Trade Secret protection act. Any unauthorized dissemination, distribution, copying or use of the information contained in this communication is strictly prohibited. If you have received this communication in error, please notify the sender by email and delete this communication immediately.

Dear Colleagues, This is the second announcement of the 2021 APN symposium to be held virtually on November 25-26. Similar to previous years, the APN symposium this year invited speakers from various countries (10 APN countries plus USA and New Zealand) on various topics, which will make the 2021 APN symposium another unique pan-Asian forum in the region. Also like last year, the meeting includes a student session for podium presentations, which will encourage the participation of future pharmacometricians. The important deadlines are: * Abstract submission deadline: Nov 10, 2021 * Registration deadline: Nov 17, 2021 Also, 2 satellite workshops will be offered, which will be scheduled as follows: <Workshop 1> Title: Pharmacometric Modeling & Simulation with Pumas.jl Instructor: Dr. Vijay Ivaturi Dates: Nov 21-24, 2021 Time: 11am - 3pm Taiwan time (16 hrs in total) <Workshop 2> Title: Disease Progress and Drug Action (By Invitation only) Instructor: Dr. Nick Holford Date: Nov 24, 2021 Time: 9am - 1pm Taiwan time (4 hrs) For Workshop 1, one can register for either all 4 days or selected day(s). For both symposium and workshops, registration is free and its procedure and the program are found at https://apn-taiwan2021.conf.tw/. For more information, contact the local host Dr. Yunn-Fang Ho of National Taiwan University of Taiwan at [email protected]<mailto:[email protected]> The APN was created to enhance regional development and networking opportunities in pharmacometrics and to provide training opportunities to future pharmacometricians across Asia. Currently the APN has 15 member countries, and the detail is found at http://www.go-apn.org/. Best regards, APN Chair Kyungsoo Park --------------------------------------- Kyungsoo Park, PhD, MD Professor of Pharmacology Yonsei University College of Medicine 50-1 Yonsei-Ro, Seoul 03722, Korea Tel +82-2-2228-1735 / Fax +82-2-313-1894 상기 메일은 지정된 수신인 만을 위한 것이며 부정경쟁 방지 및 영업비밀보호에 관한 법률을 포함하여 관련 법령에 따라 보호의 대상이 되는 영업비밀, 산업기술 등을 포함하고 있을 수 있습니다. 본 문서에 포함된 정보의 전부 또는 일부를 무단으로 제3자에게 공개, 배포, 복사 또는 사용하는 것은 엄격히 금지됩니다. 본 메일이 잘못 전송된 경우, 발신인에게 알려주시고 즉시 삭제하여 주시기 바랍니다. The above message is intended solely for the named addressee and may contain trade secret, industrial technology or privileged and confidential information otherwise protected under applicable law including the Unfair Competition Prevention and Trade Secret protection act. Any unauthorized dissemination, distribution, copying or use of the information contained in this communication is strictly prohibited. If you have received this communication in error, please notify the sender by email and delete this communication immediately.

Dear Colleagues, For the <Workshop 2> below, which will be held as a satellite course for APN2021 symposium Nov 25-26 ( https://apn-taiwan2021.conf.tw/), we have a few seats available: <Workshop 2> Title: Disease Progress and Drug Action (By Invitation only) Instructor: Dr. Nick Holford Date: Nov 24, 2021 Time: 9am - 1pm Taiwan time (4 hrs) Those who meet the 2 requirements below are welcome to contact Dr. Yunn-Fang Ho of National Taiwan University of Taiwan at [email protected]<mailto:[email protected]> , including a short CV. Participant requirements: 1) Skillful in pharmacometrics and mixed effects modelling 2) Willing to teach others in the future Best regards, APN Chair Kyungsoo Park --------------------------------------- Kyungsoo Park, PhD, MD Professor of Pharmacology Yonsei University College of Medicine 50-1 Yonsei-Ro, Seoul 03722, Korea Tel +82-2-2228-1735 / Fax +82-2-313-1894 상기 메일은 지정된 수신인 만을 위한 것이며 부정경쟁 방지 및 영업비밀보호에 관한 법률을 포함하여 관련 법령에 따라 보호의 대상이 되는 영업비밀, 산업기술 등을 포함하고 있을 수 있습니다. 본 문서에 포함된 정보의 전부 또는 일부를 무단으로 제3자에게 공개, 배포, 복사 또는 사용하는 것은 엄격히 금지됩니다. 본 메일이 잘못 전송된 경우, 발신인에게 알려주시고 즉시 삭제하여 주시기 바랍니다. The above message is intended solely for the named addressee and may contain trade secret, industrial technology or privileged and confidential information otherwise protected under applicable law including the Unfair Competition Prevention and Trade Secret protection act. Any unauthorized dissemination, distribution, copying or use of the information contained in this communication is strictly prohibited. If you have received this communication in error, please notify the sender by email and delete this communication immediately.